Matthias Bodenstedt sold $862K of MoonLake Immunotherapeutics (MLTX)

Executed Jun 22, disclosed Jun 23, 1 day later.

Value, as filed

$862K

39,120 sh × $22.04

Executed

Jun 22

the trade date, as filed

Disclosed

Jun 23

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Matthias Bodenstedt Chief Financial Officer profile →

Matthias Bodenstedt (Chief Financial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in MoonLake Immunotherapeutics (MLTX). The largest single filing was $1.6M of MLTX (85,870 sh × $18.94, as filed), executed Apr 9.

The name

MLTX

MoonLake Immunotherapeutics MLTX · Healthcare · 18 filings in 24 months ticker →

Healthcare · MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseas…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Matthias Bodenstedt in MLTX

MLTXSALE MoonLake Immunotherapeutics $297K
15,082 sh × $19.68
Exec Jun 17
Filed Jun 18 · 5:30 PM ET MLTXSALE MoonLake Immunotherapeutics $273K
13,653 sh × $20.02
Exec May 11
Filed May 13 · 5:30 PM ET MLTXSALE MoonLake Immunotherapeutics $1.6M
85,870 sh × $18.94
Exec Apr 9
Filed Apr 10 · 5:30 PM ET